Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
China
· Delayed Price · Currency is CNY 6.87
+0.19 (2.84%)
At close: Mar 10, 2026
SHE:002370 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 134.89 | 34.24 | -11.88 | -132.69 | -228.28 | 27.27 | Upgrade
|
| Depreciation & Amortization | 32.29 | 32.29 | 38.71 | 41.61 | 43.78 | 49.3 | Upgrade
|
| Other Amortization | 4.85 | 4.85 | 2.29 | 2.16 | 1.85 | 2.04 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | -0.4 | -0.04 | -4.96 | -180.64 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.69 | 5.69 | 7.61 | 47.66 | 62.63 | 17.85 | Upgrade
|
| Loss (Gain) From Sale of Investments | -55.45 | -55.45 | -3.81 | 16.68 | -24.42 | -4.93 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.03 | 0.03 | 0.63 | 1.95 | - | - | Upgrade
|
| Other Operating Activities | -82.39 | 30.59 | 47.46 | 47.77 | 48.04 | 61.26 | Upgrade
|
| Change in Accounts Receivable | 3.54 | 3.54 | 74.93 | -152.75 | 76.03 | -49.79 | Upgrade
|
| Change in Inventory | 13.82 | 13.82 | 2.83 | -26.2 | -10.51 | 82.69 | Upgrade
|
| Change in Accounts Payable | -45.49 | -45.49 | -144.02 | 168.51 | 29.22 | 12.48 | Upgrade
|
| Operating Cash Flow | 12.03 | 24.35 | 14.65 | 12.04 | -3.84 | 17.81 | Upgrade
|
| Operating Cash Flow Growth | -84.03% | 66.21% | 21.68% | - | - | - | Upgrade
|
| Capital Expenditures | -7.14 | -9.92 | -7.46 | -21.1 | -15.78 | -39.08 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | - | 0.43 | 0.15 | 129.6 | 148.06 | Upgrade
|
| Cash Acquisitions | -60 | - | - | - | - | - | Upgrade
|
| Divestitures | 126.27 | - | - | - | - | 7.45 | Upgrade
|
| Investment in Securities | 32.08 | 0.9 | 4.99 | - | 1.92 | 3.19 | Upgrade
|
| Other Investing Activities | 65.68 | 16.02 | 2.03 | 5.18 | 14.75 | 7.36 | Upgrade
|
| Investing Cash Flow | 156.9 | 7.01 | -0.01 | -15.76 | 130.33 | 126.98 | Upgrade
|
| Short-Term Debt Issued | - | 30 | 50 | 80 | - | - | Upgrade
|
| Total Debt Issued | 30 | 30 | 50 | 80 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -50 | -50 | -140 | -84 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.34 | -1.08 | -1.42 | -76 | Upgrade
|
| Total Debt Repaid | -277.23 | -50 | -50.34 | -141.08 | -85.42 | -76 | Upgrade
|
| Net Debt Issued (Repaid) | -247.23 | -20 | -0.34 | -61.08 | -85.42 | -76 | Upgrade
|
| Common Dividends Paid | -37.37 | -11.9 | -16.5 | -13.88 | -13.34 | -15.01 | Upgrade
|
| Other Financing Activities | -0 | -0 | -0 | - | -109.55 | -337.61 | Upgrade
|
| Financing Cash Flow | -284.6 | -31.91 | -16.84 | -74.96 | -208.31 | -428.62 | Upgrade
|
| Net Cash Flow | -115.67 | -0.54 | -2.19 | -78.68 | -81.82 | -283.84 | Upgrade
|
| Free Cash Flow | 4.9 | 14.44 | 7.19 | -9.06 | -19.62 | -21.27 | Upgrade
|
| Free Cash Flow Growth | -92.48% | 100.70% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 1.50% | 3.56% | 1.71% | -2.43% | -6.23% | -4.13% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.02 | 0.01 | -0.02 | -0.04 | -0.04 | Upgrade
|
| Cash Income Tax Paid | 17.3 | 22.79 | 26.8 | 9.08 | 26.89 | 35.91 | Upgrade
|
| Levered Free Cash Flow | 4.81 | -2.67 | -63.12 | -37.03 | -79.36 | 32.6 | Upgrade
|
| Unlevered Free Cash Flow | 29.1 | 16.45 | -33.46 | -4.33 | -43.81 | 75.15 | Upgrade
|
| Change in Working Capital | -27.89 | -27.89 | -65.95 | -13.06 | 97.51 | 45.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.